Drug intelligence / Profile preview

iodine + selenium

Development stage
Unknown
Lead developer
OMNIFARMA
Modality
Small Molecules
Administration
Oral
01

Overview

YoSen (ЙоСен) is a mineral dietary supplement developed by Omnifarma Kyiv, formulated to provide a synergistic combination of iodine and selenium. It is primarily used for the prevention of iodine and selenium deficiencies, which are essential for maintaining normal thyroid function. Iodine serves as a fundamental building block for the thyroid hormones thyroxine (T4) and triiodothyronine (T3). Selenium acts as a vital cofactor for the deiodinase enzymes (DIO1, DIO2) that convert T4 into its active form, T3, and for glutathione peroxidases that protect the thyroid gland from oxidative stress during hormone production. The product is available in specific dosages for adults, children, and pregnant women to support metabolic health and prevent conditions such as endemic goiter.

Brand names
ЙоСенYoSen
Other names
iodine and selenium
02

Targets

DIO1 (Type I iodothyronine deiodinase)GPX4 (Glutathione peroxidase 4)TPO (Thyroid peroxidase)DIO2 (Iodothyronine deiodinase type 2)

Beyond the preview

Go deeper on iodine + selenium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine + selenium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call